Nalaganje...
Lessons in precision oncology from neoadjuvant endocrine therapy trials in ER+ breast cancer
For post-menopausal women with clinical stage II/III estrogen receptor positive (ER+) breast cancer neoadjuvant endocrine therapy (NET) is an under-utilized and low-toxicity alternative to chemotherapy for increasing breast conservation rates. Individual responses to endocrine therapy can also be us...
Shranjeno v:
| izdano v: | Breast |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5592154/ https://ncbi.nlm.nih.gov/pubmed/28669712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2017.06.039 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|